You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》叮噹健康向港交所(00388.HK)遞交招股書
內地數字醫療到家公司叮噹健康向港交所(00388.HK)遞交招股書,擬在香港主板掛牌上市,中金公司、招銀國際爲聯席保薦人,是繼其於去年6月22日遞表失效之後再一次申請上市。 叮噹健康綜合線上及線下營運,向用戶提供全套醫療健康到家產品和服務組合,如快藥、在線診療及慢病與健康管理。於2019年、2020年及2021年,叮噹健康收入約12.8億元、約22.3億元及36.8億元人民幣,2019年至2021年的複合年增長率約爲69.8%。 截至最後實際可行日期,叮噹健康擁有348個智慧藥房、團隊擁有18名全職醫生及73名兼職醫生、通過與 第三方醫療機構的合作與跟隨產生關聯的800多名外部醫生,以及427名藥師,並擁有185家分銷商。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account